Results 1-10 of 55
Publication DateTitleAuthor(s)
25-Feb-2016Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental AtherosclerosisKhamis, RY; Woollard, KJ; Hyde, GD; Boyle, JJ; Bicknell, C, et al
11-May-2016Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease.De Guio, F; Jouvent, E; Biessels, GJ; Black, SE; Brayne, C, et al
19-Sep-2016Multimodal population brain imaging in the UK Biobank prospective epidemiological studyMiller, KL; Alfaro-Almagro, F; Bangerter, NK; Thomas, DL; Yacoub, E, et al
1-Mar-2017Personalised medicine for multiple sclerosis care.Gafson, A; Craner, MJ; Matthews, PM
1-Feb-2016UK Biobank's cardiovascular magnetic resonance protocol.Petersen, SE; Matthews, PM; Francis, JM; Robson, MD; Zemrak, F, et al
1-Aug-2011Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humansRabiner, EA; Beaver, J; Makwana, A; Searle, G; Long, C, et al
1-Jan-2011Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein LigandsOwen, DRJ; Gunn, RN; Rabiner, EA; Bennacef, I; Fujita, M, et al
1-Jan-2012An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28Owen, DR; Yeo, AJ; Gunn, RN; Song, K; Wadsworth, G, et al
1-Sep-2015Positron emission tomography imaging in multiple sclerosis highlights a diffuse inflammatory response in brain that appears normal on conventional magnetic resonance imagingDatta, G; Battaglini, M; Scott, G; Yaldizli, O; Ribeiro, AS, et al
1-Sep-2015Hippocampal inflammation and depression in multiple sclerosis: integrating evidence from TSPO PET and resting state fMRIColasanti, A; Guo, Q; Giannetti, P; Wall, M; Newbould, RD, et al